ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2015
Results of Annual General Meeting held on 24 April 2015
AstraZeneca PLC announced the results of the voting at its Annual General
Meeting today. As proposed in the Notice of AGM, all Resolutions were decided by
poll vote. Resolutions 1 - 8 were passed as ordinary resolutions and resolutions
9 - 12 were passed as special resolutions.
RESOLUTION VOTES FOR % OF VOTES % OF VOTES CAST TOTAL
VOTES
VOTES AGAINST VOTES IN TOTAL VOTES
WITHHELD
CAST CAST CAST AS
A %
OF
ISSUED
SHARE
CAPITAL
1 To receive 877,576,463 99.67 2,921,581 0.33 880,498,044 69.68%
10,675,935
the
Company's
Accounts and
the Reports
of the
Directors
and Auditor
for the year
ended 31
December
2014
2 To confirm 886,527,613 99.66 2,986,602 0.34 889,514,215 70.40%
1,659,763
dividends
3 To re 876,751,815 98.61 12,397,571 1.39 889,149,386 70.37%
2,024,593
-appoint
KPMG LLP,
London as
Auditor
4 To authorise 887,495,062 99.82 1,629,520 0.18 889,124,582 70.37%
2,049,398
the
Directors to
agree the
remuneration
of the
Auditor
5a To re-elect 851,461,560 95.76 37,705,142 4.24 889,166,702 70.37%
2,007,277
Leif
Johansson as
a Director
5b To re-elect 888,590,119 99.95 426,241 0.05 889,016,360 70.36%
2,157,620
Pascal
Soriot as a
Director
5c To re-elect 885,602,969 99.62 3,374,856 0.38 888,977,825 70.36%
2,196,155
Marc Dunoyer
as a
Director
5d To elect 888,638,513 99.96 351,446 0.04 888,989,959 70.36%
2,184,021
Cori
Bargmann as
a Director
5e To re-elect 888,552,754 99.95 465,106 0.05 889,017,860 70.36%
2,156,120
Geneviève
Berger as a
Director
5f To re-elect 880,639,560 99.88 1,091,107 0.12 881,730,667 69.78%
9,443,312
Bruce
Burlington
as a
Director
5g To re-elect 888,587,093 99.95 465,731 0.05 889,052,824 70.36%
2,121,156
Ann Cairns
as a
Director
5h To re-elect 876,994,757 99.46 4,732,631 0.54 881,727,388 69.78%
9,445,684
Graham
Chipchase as
a Director
5i To re-elect 880,585,784 99.87 1,137,760 0.13 881,723,544 69.78%
9,450,753
Jean
-Philippe
Courtois as
a Director
5j To re-elect 855,335,488 99.27 6,300,712 0.73 861,636,200 68.19%
29,537,348
Rudy Markham
as a
Director
5k To re-elect 888,387,120 99.93 582,556 0.07 888,969,676 70.36%
2,204,192
Shriti
Vadera as a
Director
5l To re-elect 846,091,821 98.19 15,599,701 1.81 861,691,522 68.20%
29,482,025
Marcus
Wallenberg
as a
Director
6 To approve 739,049,685 84.11 139,601,566 15.89 878,651,251 69.54%
12,522,725
the Annual
Report on
Remuneration
for the year
ended 31
December
2014
7 To authorise 859,081,444 97.36 23,307,997 2.64 882,389,441 69.83%
8,784,535
limited EU
political
donations
8 To authorise 808,454,239 91.14 78,551,101 8.86 887,005,340 70.20%
4,168,208
the
Directors to
allot shares
9 To authorise 875,263,416 98.61 12,347,679 1.39 887,611,095 70.25%
3,562,455
the
Directors to
disapply pre
-emption
rights
10 To authorise 876,130,644 98.54 13,023,264 1.46 889,153,908 70.37%
2,019,960
the Company
to purchase
its own
shares
11 To reduce 778,280,838 87.53 110,881,255 12.47 889,162,093 70.37%
2,011,885
the notice
period for
general
meetings
12 To adopt new 886,456,629 99.90 900,552 0.10 887,357,181 70.23%
3,813,971
Articles of
Association
Issued capital
As at 22 April 2015, the number of issued shares of the Company was
1,263,544,938, ordinary shares, which was the total number of shares entitling
the holders to attend and vote for or against all the resolutions at the AGM. In
accordance with the Company's Articles of Association, on a poll every member
present in person or by proxy has one vote for every share held.
A C N Kemp
Company Secretary
24 April 2015
Result of AGM
| Source: AstraZeneca PLC
Attachments
